Avita Medical Inc (Avita Medical) is a commercial-stage regenerative medical device company. It develops products to meet the unmet medical needs of patients in conditions such as burns and chronic wounds, besides aesthetics and skin defects. The company's proprietary application technology provides treatment harnessing the regenerative properties of the skin of patients. The company’s lead product is RECELL System, a single-use (disposable) stand-alone, battery operated device, which is approved for the treatment of acute thermal burns in adult patients; and also for treating vitiligo and full-thickness skin defects in the US. The company has operations in the US, Australia, Japan and the UK, besides the European Union. Avita Medical is headquartered in Valencia, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Avita Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Avita Medical Inc Company Overview
- Avita Medical Inc Company Snapshot
- Avita Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Avita Medical Inc - Pipeline Analysis Overview
- Business Description
- Avita Medical Inc - Key Facts
- Avita Medical Inc - Major Products and Services
- Avita Medical Inc Pipeline Products by Development Stage
- Avita Medical Inc Pipeline Products Overview
- ReCell - Epidermolysis Bullosa
- ReCell - Epidermolysis Bullosa Product Overview
- ReCell - Hutchinson-Gilford Progeria Syndrome
- ReCell - Hutchinson-Gilford Progeria Syndrome Product Overview
- ReCell - Skin Rejuvenation
- ReCell - Skin Rejuvenation Product Overview
- ReCell - Trauma Wounds
- ReCell - Trauma Wounds Product Overview
- ReCell - Vitiligo
- ReCell - Vitiligo Product Overview
- ReCell Go - Thermal Burns Full Thickness
- ReCell Go - Thermal Burns Full Thickness Product Overview
- ReCell Go - Thermal Burns Partial Thickness
- ReCell Go - Thermal Burns Partial Thickness Product Overview
- ReCell Go Mini
- ReCell Go Mini Product Overview
- Avita Medical Inc - Key Competitors
- Avita Medical Inc - Key Employees
- Avita Medical Inc - Key Employee Biographies
- Avita Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Avita Medical Inc, Recent Developments
- Jul 31, 2024: AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
- Jun 05, 2024: AVITA Medical Achieves Milestone with First Case Using RECELL GO
- Feb 29, 2024: AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
- Nov 10, 2023: AVITA partners with PolyMedics to expand Recell into Europe
- Nov 09, 2023: AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
- Oct 02, 2023: AVITA Medical premarket FDA Approval
- Sep 25, 2023: AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma
- Sep 21, 2023: AVITA Medical : Change of Registry Address Notification
- Jun 29, 2023: AVITA Medical Submits FDA PMA Supplement for RECELL GO
- Jun 19, 2023: Avita Medical obtains FDA approval of RECELL system for treating vitiligo
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Avita Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Avita Medical Inc Pipeline Products by Equipment Type
- Avita Medical Inc Pipeline Products by Indication
- Avita Medical Inc, Key Facts
- Avita Medical Inc, Major Products and Services
- Avita Medical Inc Number of Pipeline Products by Development Stage
- Avita Medical Inc Pipeline Products Summary by Development Stage
- ReCell - Epidermolysis Bullosa - Product Status
- ReCell - Epidermolysis Bullosa - Product Description
- ReCell - Hutchinson-Gilford Progeria Syndrome - Product Status
- ReCell - Hutchinson-Gilford Progeria Syndrome - Product Description
- ReCell - Skin Rejuvenation - Product Status
- ReCell - Skin Rejuvenation - Product Description
- ReCell - Trauma Wounds - Product Status
- ReCell - Trauma Wounds - Product Description
- ReCell - Vitiligo - Product Status
- ReCell - Vitiligo - Product Description
- ReCell Go - Thermal Burns Full Thickness - Product Status
- ReCell Go - Thermal Burns Full Thickness - Product Description
- ReCell Go - Thermal Burns Partial Thickness - Product Status
- ReCell Go - Thermal Burns Partial Thickness - Product Description
- ReCell Go Mini - Product Status
- ReCell Go Mini - Product Description
- Avita Medical Inc, Key Employees
- Avita Medical Inc, Key Employee Biographies
- Avita Medical Inc, Subsidiaries
- Avita Medical Inc, Joint Venture
- Glossary
- Avita Medical Inc Pipeline Products by Equipment Type
- Avita Medical Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Pfizer SA de CV
- Organogenesis Holdings Inc
- Johnson & Johnson
- Smith & Nephew Plc
- Vericel Corp
